Comparison of Satisfied and Dissatisfied Patients
| Satisfied (n = 326) | Dissatisfied (n = 117) | P* | |
|---|---|---|---|
| Female | 84% | 82% | 0.72 |
| Midas category 3 or 4 (moderate-severe disability) | 54% | 78% | P < .001 |
| Drugs used for migraine | |||
| Analgesics | 56% | 59% | 0.67 |
| Combination drugs | 44% | 40% | 0.56 |
| Narcotics | 30% | 29% | 0.93 |
| Current triptan use | 61% | 38% | P < .001 |
| Discontinued triptans | 22% | 42% | P < .001 |
| Never used triptans | 17% | 21% | 0.35 |
| Experience of >1 triptan | 47% | 43% | 0.50 |
| Private insurance | 85% | 87% | 0.67 |
| Insurance pays most or all of migraine medication | 60% | 48% | 0.03 |
| Insurance pays none of migraine medication | 12% | 19% | 0.09 |
* χ2 analysis.